News related to Lovenox (Enoxaparin) and/or conditions it is approved for
AHA: Rivaroxaban Cuts Risk of VTE in Joint Replacement (CME/CE)
Source: MedPage Today Surgery [2009.11.18]
ORLANDO (MedPage Today) -- Rivaroxaban, an investigative oral factor Xa inhibitor, appears to reduce the risk of deep vein thrombosis by 50% among hip and knee replacement patients when compared with enoxaparin (Lovenox), researchers reported here.
Deep Vein Thrombosis (DVT)
Source: MedicineNet Antiphospholipid Syndrome Specialty [2008.04.30]
Title: Deep Vein Thrombosis (DVT)
Category: Diseases and Conditions
Created: 2/15/2000 10:55:00 PM
Last Editorial Review: 4/30/2008
|
